TransMedics Group, Inc. - היקף נכסי החברה TMDX

TransMedics Group (TMDX) develops autonomous OCS systems for organ preservation, which translates into profits from console sales and hospital services. The total asset value on the GURU.Markets website demonstrates this growth, where the value of 1177.80 expresses the metric level. Such scale confirms the company's leadership in transplant automation through the implementation of intelligent perfusion platforms.

Analyzing the aggregate of resources combining capital and liabilities—which are reverse-calculated here via return on assets (ROA)—is critical for constructing a defensive portfolio. In the case of TransMedics Group (TMDX), the growth of asset value based on ROA reflects the scaling of high-tech production and the implementation of sustainable ESG standards within transplantation modules, confirming the resilience of the business's material base.